Navigation Links
Microbix Biosystems Provides a Corporate Update
Date:10/29/2009

, pharmaceutical and biotechnology industries. His previous experience includes Bayer Pharmaceuticals, where he last served as Vice President of Business Development for Biotechnology. Dr. Cochran also served as CEO and executive director of the Blanchette Rockefeller Neurosciences Institute; and was a senior member of MDS Capital, a Toronto-based Healthcare venture capital group, where he was responsible for their San Francisco venture business and several MDS invested companies. Dr. Cochran holds a doctorate in microbiology and immunology from Queen's University, Kingston, Ontario; a master's in microbiology from the University of Guelph, Ontario, and a bachelor's degree from the University of Toronto.

-------

Microbix is on the threshold of significant growth powered by the following expected developments within the year:

      - Become cash-flow positive.
      - Begin construction on the first phase of the Microbix/Hunan JV
        influenza manufacturing facility in China.
      - Receive its Canadian Urokinase license from Health Canada.
      - Launch KINLYTIC in Canada and other markets.
      - Announce new partnerships in its SST program.

Microbix has the people, the products and the pipeline to deliver on the goals of its business strategy and significantly build shareholder value. The Company thanks its employees for their efforts, its partners for their interest and its shareholders for their continued support.

About Microbix

--------------

Microbix specializes in the development of biological technologies and commercializing them through global partners. The Company has intellectual property in large market biotherapeutic drugs, vaccine technologies and animal reproduction technologies. Established in 1988, Microbix is headquartered in Toronto.

This press release contains forward-looking statements, which are subject to risks and un
'/>"/>

SOURCE Microbix Biosystems Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
2. Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009
3. Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline
4. Microbix Announces A New Technology Platform For The SST Project
5. Microbix Sales Grow Over 30% In The Second Quarter; Up 43% In The First Half 09
6. Microbix Files First Patent Applications On Novel Technology Platform For Large Semen Sexing Market
7. Microbix Sales Grow 22% For Nine Months
8. Microbix And Hunan Biopharmaceutical To Build Asias Largest Influenza Vaccine Facility
9. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
10. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
11. Primera Biosystems Raises $21 Million in Series B Private Round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... As part of the long-term strategic approach, ... region during 2014 with potential global expansion. , "We ... DZS to manage our clinical trials globally and in ... R&D and President of SBI pharmaceuticals MENA, Dr. Riyadh ... a focus on utilizing eClinical software and flexible team ...
(Date:7/24/2014)... CA (PRWEB) July 24, 2014 ... reporting of molecular diagnostic test results. It also ... necessary for the validation and reporting of high ... Molecular diagnostics is a rapidly growing area of ... disease, genetic predisposition, cancer, and companion diagnostics in ...
(Date:7/23/2014)... YORK , July 24, 2014 ... Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First ... "Immune" or "the Company"), announced a collaboration to ... pemphigoid last night at an event attended by ... interested parties. Lyfebulb is a health and wellness ...
(Date:7/23/2014)... Al Khaimah, United Arab Emirates (UAE) (PRWEB) July 23, ... firm Grace Century recently announced that its ... Dr. Jim Vaught , Ph.D. to its growing Advisory ... said, “We are very pleased to have Dr. Vaught ... with the scientific depth and expertise that Provia’s management ...
Breaking Biology Technology:SBI Pharmaceuticals Co. Ltd. Enters into Preferred Provider Agreement with DZS Clinical Services 2New DNA-barcode Patent Virtually Eliminates False Test Results and Sample Mix-up 2Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 2Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 3Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 4Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin 5Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 2Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 3Provia Laboratories Adds Dr. Jim Vaught, Ph.D., Former Chief of BBRB, to Advisory Board 4
... BRANFORD, Connecticut and STATE COLLEGE, Pennsylvania, May 9, ... Roche Company, and SoftGenetics announced today that the ... designed to provide users of 454 Sequencing Systems ... options provided by SoftGenetics NextGENe® software. ...
... JERICHO, N.Y., May 8, 2012 Health Care ... response to continued recent devastating natural and man-made ... the HCCS online training course, "Bioterrorism and Disaster ... (Logo:  http://photos.prnewswire.com/prnh/20061010/NYTU194LOGO ) "HCCS ...
... COPENHAGEN, May 8, 2012  Ekahau ... Location Systems (RTLS), today announced the launch of its newest ... Pager .  The B4 features an OLED text display and multiple ... to acknowledge receipt or to initiate calls and alarms. A unique ...
Cached Biology Technology:Roche 454 Life Sciences and SoftGenetics Sign Co-Promotion Agreement for Next-Gen Sequencing Software Tools 2Roche 454 Life Sciences and SoftGenetics Sign Co-Promotion Agreement for Next-Gen Sequencing Software Tools 3Free Disaster Preparedness Online Training Course 2Ekahau Launches Next Generation Wi-Fi RTLS Staff Badge and Pager 2Ekahau Launches Next Generation Wi-Fi RTLS Staff Badge and Pager 3
(Date:7/23/2014)... This news release is available in German . ... shape and stability to cells, drive metabolic processes and ... into complex three-dimensional shapes. Scientists at the Max Planck ... that proteins can be constructed of similar amino acid ... suggests that the proteins that exist today arose from ...
(Date:7/23/2014)... Innovative Networking in personalized cancer medicine, (the WIN consortium), ... Thomas Jefferson University will be one of ... this prestigious group in the Tri-State Area. The goal ... personalized medicine to the patient by forging collaborations between ... participation in the WIN consortium means Jefferson cancer patients ...
(Date:7/23/2014)... As local and national governments struggle to deal with ... now refining the picture of just how much there ... the ACS journal Environmental Science & Technology , ... that developed countries discard floods into just seven developing ... people who live there. , Knut Breivik and colleagues ...
Breaking Biology News(10 mins):Protein evolution follows a modular principle 2New partnership brings more personalized cancer treatment to Philadelphia 2
... 2011) -- In a biotechnological tour de force, Rice ... for rapidly converting simple glucose into biofuels and petrochemical ... , Rice,s team described how it reversed one of ... beta oxidation cycle -- to engineer bacteria that produce ...
... Cambridge, Mass. - August 10, 2011 - Between conception ... meters long, looping and coiling within the tiny abdomen. ... loops into the same formationhowever, until now, it has ... experimental observations, biological and biophysical manipulations, theory, and computation, ...
... Genetically engineered spider silk could help overcome a major ... according to a new study that reported development and successful ... ACS, journal Bioconjugate Chemistry . David Kaplan and ... genes to prevent or treat disease requires safe and ...
Cached Biology News:Metabolism in reverse: Making biofuels at full-throttle pace 2Gut coils with help from its elastic neighbor 2Gut coils with help from its elastic neighbor 3
... The epitope is specific for Kir2.1 ... other known protein.,SPECIES REACTIVITIES: The ... bovine, porcine and guinea pig. It ... mouse (17/19 residues) and chick (15/19 ...
Anti-20S proteasome subunits alpha 1, 2, 3, 5, 6 & 7, clone MCP231 Immunogen: Dinitrophenylated proteasomes Molecular Weight: 29 and 32 kDa....
Tight junctions are complexes of proteins that create intercellular boundaries between the plasma membrane domains of epithelial and endothelial cells. Antigen: Synthetic peptide corresponding to...
Biotin anti-mouse CD48...
Biology Products: